Flagship Ventures Fund Iv General Partner Llc

Affiliations

  • Large Shareholder at Rubius Therapeutics Inc. (RUBY), 2021-03-23
  • Large Shareholder at Kaleido Biosciences Inc. (KLDO), 2021-02-10
  • Large Shareholder at Evelo Biosciences Inc. (EVLO), 2021-02-04
  • Large Shareholder at Seres Therapeutics Inc. (MCRB), 2020-11-25
  • Large Shareholder, Director at Moderna Inc. (MRNA), 2020-08-20
  • Large Shareholder at Axcella Health Inc. (AXLA), 2020-05-20
  • Large Shareholder at Transmedics Group Inc. (TMDX), 2019-10-31
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2017-08-21
  • Large Shareholder at Eleven Biotherapeutics Inc. (EBIO), 2016-09-26
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-08-15
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2014-08-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RUBY $29.00 70,000 Large Shareholder 2,633,703 2021-03-19 Filing
RUBY $29.00 70,000 Large Shareholder 5,859,414 2021-03-19 Filing
RUBY $29.00 70,000 Large Shareholder 15,393,593 2021-03-19 Filing
KLDO $11.50 71,667 Large Shareholder 738,333 2021-02-08 Filing
KLDO $11.50 71,667 Large Shareholder 2,982,639 2021-02-08 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MRNA $70.18 10,746 Large Shareholder, Director 6,420,766 2020-05-22 Filing
MRNA $69.45 69,254 Large Shareholder, Director 6,431,512 2020-05-22 Filing
MRNA $70.18 56,406 Large Shareholder, Director 21,986,399 2020-05-22 Filing
MRNA $69.45 363,594 Large Shareholder, Director 22,042,805 2020-05-22 Filing
MRNA $72.44 367 Large Shareholder, Director 6,500,766 2020-05-21 Filing